The Search for New Psychedelics

The Search for New Psychedelics

Up next

What science says about endless phone scrolling

How much screen time is too much? In this episode of Science Quickly, Scientific American associate editor Allison Parshall explores the growing debate over screen addiction and problematic social media use. From landmark lawsuits against tech companies to the psychology behind e ...  Show more

Are Blue Zones real?

Longevity research has fueled books, documentaries and billion-dollar industries, but how much of it stands up to scrutiny? In this episode, researcher Saul Justin Newman explains why he believes that the evidence behind Blue Zones, antiaging interventions and some of the biggest ...  Show more

Recommended Episodes

Funding for Research on Psychedelics Is on the Rise, Along with Scientists' Hopes for Using Them
Science Quickly

As interest and support for psychedelic research grows, scientists share their hopes for the future. Learn more about your ad choices. Visit megaphone.fm/adchoices 

Psychedelics: The Manifested Mind, Part 5
Stuff To Blow Your Mind

What are psychedelics? How have these substances influenced human minds and culture? What exactly do they invoke in the brain and how could a renaissance of scientific study into their properties improve our lives? In this series of Stuff to Blow Your Mind episodes, Robert and Jo ...  Show more

Psychedelics Playlist: The Manifested Mind, Part 5
Stuff To Blow Your Mind

What are psychedelics? How have these substances influenced human minds and culture? What exactly do they invoke in the brain and how could a renaissance of scientific study into their properties improve our lives? In this series of Stuff to Blow Your Mind episodes, Robert and Jo ...  Show more

Bonus Sample: The Future of Psychedelics
Conspirituality

Derek investigates a recent NY Times essay by Michael Pollan as an entry point to discuss big questions in psychedelics and conspirituality: How do we honor indigenous traditions as psychedelics are legalized (and monetized)? What dangers lie ahead as pharmaceutical companies and ...  Show more